Drugs / iparacetamol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05904912 Background | Jun → Dec 2023 | aortic valve stenosis | Medipol University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iparacetamol | “In the postoperative period, patients will be administered iparacetamol iv 1 gr 3x1.” NCT05904912 ↗ |
| Route | Intravenous | “In the postoperative period, patients will be administered iparacetamol iv 1 gr 3x1.” NCT05904912 ↗ |